Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CalciMedica ( (CALC) ) has issued an announcement.
On January 10, 2025, Eric Bjerkholt resigned from the board of directors and audit committee of CalciMedica, Inc., effective January 15, 2025. His resignation was not due to any disagreements with the company. On January 13, 2025, the board appointed Alan Glicklich, M.D., as a Class I director, effective January 15, 2025, with his term expiring in 2027. Dr. Glicklich’s appointment involves no special arrangements, and he will receive an annual cash retainer and stock options as per company policy.
More about CalciMedica
YTD Price Performance: -11.85%
Average Trading Volume: 62,383
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $40.72M
See more insights into CALC stock on TipRanks’ Stock Analysis page.